Clinical Trials Browser

Phase 3 × Uveal Melanoma × MART-1 Antigen × Clear all

NCT00036816 2012-09-24

Vaccine Therapy in Treating Patients With Melanoma of the Eye

Phase 3 Terminated

Uveal Melanoma